Regulation of response to radiotherapy by β-arrestin1 in Non-small cell lung cancer

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Beta-arrestin1 (β-arrestin1) is a crucial scaffold protein in various signaling pathways.
• Limited research exists on the role of β-arrestin1 in the DNA damage response (DDR).

Purpose of the Study:

• To investigate the impact of β-arrestin1 on DNA damage response, apoptosis, and proliferation in non-small cell lung cancer (NSCLC) cells.
• To explore the correlation between β-arrestin1 levels and DDR markers in NSCLC tissues.
• To elucidate the interaction of β-arrestin1 with key DDR proteins like ATR and H2AX.

Main Methods:

• Utilized NSCLC cell lines with β-arrestin1 overexpression or knockdown.
• Assessed cell proliferation, viability, and apoptosis using MTT, colony formation, and flow cytometry.
• Analyzed DDR, apoptosis, ERK, and NF-κB pathway activation via Western blotting and qRT-PCR.
• Investigated β-arrestin1 interactions with ATR and H2AX using Co-IP and detected DNA damage with comet assays.

Main Results:

• β-arrestin1 mRNA levels positively correlated with ATR and H2AX in NSCLC tissues.
• β-arrestin1 directly or indirectly binds to ATR and H2AX.
• Overexpression of β-arrestin1 amplified radiation-induced DDR, DNA damage, and apoptosis.
• Suppression of β-arrestin1 reduced proliferation and attenuated radiation-induced ERK and NF-κB activation.

Conclusions:

• β-arrestin1 plays a significant role in enhancing the DDR and apoptosis in NSCLC cells upon radiation exposure.
• β-arrestin1 modulates NSCLC radiosensitivity by influencing DDR, proliferation, and associated signaling pathways.
• Targeting β-arrestin1 presents a potential therapeutic strategy for NSCLC.